Evidence map›Paper›PMID 32567421›Full record

ArticleThe Journal of international medical research2020

Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China.

Yanliang Ma, Daishun Liu, Yingqun Ji, Xuemei Wei, Dianzhu Pan, Fei Xu, Qingguo Di, Xiaoju Chen, Fengming Luo, Jiujin Zhang and 10 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. A systematic literature review of the clinical and socioeconomic burden of bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  3. Prevalence of bronchiectasis: a narrative review.Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 1 country.

Yanliang MaDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-8491-391X
Daishun LiuDepartment of Respiratory and Critical Care Medicine, The First People's Hospital of Zunyi City, Zunyi City, Guizhou Province, China.
Yingqun JiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xuemei WeiDepartment of Respiratory and Critical Care Medicine, The People's Hospital of the Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Dianzhu PanDepartment of Respiratory Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Fei XuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Qingguo DiDepartment of Pulmonary and Critical Care Medicine Ward 1, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Xiaoju ChenDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Fengming LuoDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Jiujin ZhangDepartment of Respiratory and Critical Care Medicine, Guangxi Yulin First People's Hospital, Yulin, Guangxi, China.
Guiying OuDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
Yan ZhangDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
Kaishu LiDepartment of Respiratory and Critical Care Medicine, Binzhou People's Hospital, Binzhou, Shandong, China.
Dong ZhangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China.
Wanping WangDepartment of Respiratory and Critical Care Medicine, Changzhi People's Hospital of Shanxi, Changzhi, Shanxi, China.
Jinfu XuDepartment of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Shanghai, China.
Jianying LiDepartment of Respiratory Medicine, Xi'an Central Hospital Affiliated to Medical College of Xi'an JiaoTong University, Xian, Shanxi, China.
Dan ZhuDepartment of Respiratory Medicine, Jinhua Central Hospital of Zhejiang, Jinhua, Zhejiang, China.
Feng TianDepartment of Respiratory Medicine, Linyi People's Hospital, Linyi, Shandong, China.
Manqi FanDepartment of Respiratory Medicine, Kunming General Hospital of Chengdu Military Command, Kunming, Yunnan, China All authors contributed equally to this paper.
Peking University · CNAffiliated Hospital of North Sichuan Medical College · CNBaotou Medical College · CNBinzhou People's Hospital · CNCangzhou Central Hospital · CNChangzhi Medical College · CNDalian Medical University · CNFirst People’s Hospital of Zunyi · CNJinhua Central Hospital · CNJinzhou Medical University · CNKunming General Hospital of Chengdu Military Command · CNLinyi People's Hospital · CNNanchang University · CNPeople's Hospital of Xinjiang Uygur Autonomous Region · CNShanghai Pulmonary Hospital · CNSichuan University · CNXian Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBronchiectasis is a common chronic airway disease. We investigated the economic burden and associated factors of bronchiectasis in China.

methodsIn this multicenter retrospective cohort study, we reviewed medical records of patients admitted to 18 tertiary hospitals during 2010 to 2014 with a bronchiectasis-related diagnosis.

resultsA total 5469 patients with bronchiectasis were admitted, accounting for 3.13% ± 1.80% of all discharged patients with any diagnosis during the same period; 13 patients died upon discharge. The median hospitalization cost was RMB 8421.52 (RMB 5849.88-12,294.47). Risk factors associated with hospitalization costs included age at admission (>70 vs. <40 years, odds ratio (OR) = 1.221, 95% confidence interval (CI) = 1.082-1.379; >80 vs. <40 years, OR = 1.251, 95% CI = 1.089-1.438), smoking (≤15 packs/year vs. non-smokers, OR = 1.125, 95% CI = 1.006-1.271; >15 packs/year vs. non-smokers, OR = 1.127, 95% CI = 1.062-1.228), length of hospitalization (OR = 1.05, 95% CI = 1.046-1.054), combination antibiotic treatment (OR = 1.089, 95% CI = 1.033-1.148), cough (OR = 0.851, 95% CI = 0.751-0.965), dyspnea (OR = 0.93, 95% CI = 0.878-0.984), chronic obstructive pulmonary disease (OR = 0.935, 95% CI = 0.878-0.996), respiratory failure (OR = 0.923, 95% CI = 0.862-0.989), cor pulmonale (OR = 0.919, 95% CI = 0.859-0.982), and death (OR = 1.816, 95% CI = 1.113-2.838).

conclusionsAge, smoking status, symptoms, and respiratory comorbidities were associated with hospitalization costs of bronchiectasis.

Indexed as

AdultAgedAged, 80 and overBronchiectasisChinaCohort StudiesComorbidityCoughDisease ProgressionFemaleForced Expiratory VolumeHospitalizationHospitalsHumansMaleMiddle Agedacute exacerbationBronchiectasiseconomic burden of diseasehospitalizationhospitalization costslength of hospital stay

Identifiers

PMID32567421
PMCPMC7309388
OpenAlexW3035878029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.